Oncology

Browse 60 topics in oncology.

60 results

Acute Leukaemia

Epidemiology: AML: Median age 68 years, incidence 4.3 per 100,000 in adults ALL: Bimodal distribution (peak ages 2-5 years and 50 years), incidence 1.7 per 100,000 Male predominance in both subtypes (M:F ratio...

6 Jan 2026Peer reviewed
Haematology
Oncology
High evidence

Basal Cell Carcinoma

While BCC has an exceptionally low metastatic rate (less than 0.1%), it remains a significant clinical challenge due to its high incidence, potential for local invasion and tissue destruction, and substantial...

Skin Cancer8 Jan 2026Peer reviewed
Dermatology
Plastic Surgery
High evidence
+2

Bladder Cancer

Recent advances in molecular characterization have identified distinct molecular subtypes (luminal and basal) with differential responses to therapy, enabling precision oncology approaches. The treatment landscape for...

Genitourinary Oncology11 Jan 2026Peer reviewed
Urology
Oncology
High evidence
+1

Breaking Bad News (SPIKES)

Breaking bad news is one of the most challenging and important communication tasks in clinical medicine. It refers to the process of conveying information that adversely and seriously affects an individual's view of...

Communication Skills11 Jan 2026Peer reviewed
Palliative Care
General Practice
High evidence
+2

Breast Cancer

Triple assessment—comprising clinical examination, imaging (mammography/ultrasound), and tissue diagnosis (core biopsy)—remains the diagnostic gold standard. Management is multimodal, integrating surgery...

Breast Surgery6 Jan 2025Peer reviewed
Oncology
Radiology
High evidence
+1

Cancer Surgery and Anaesthesia

What is it? Anaesthesia for cancer surgery requires specialized knowledge of cancer biology, immunosuppression effects, optimal surgical timing, and perioperative considerations that differ significantly from...

Perioperative Medicine3 Feb 2026
Anaesthesia
Perioperative Medicine
A evidence
+1

Carcinoid Syndrome

Key Facts Tumour Origin : Midgut NETs (Appendix, Ileum) most common to cause syndrome. Syndrome Appears : Usually only after Liver Metastases (Hepatic first-pass metabolism bypassed). 10% of NET patients develop the...

Neuroendocrine Tumours10 Jan 2026Peer reviewed
Endocrinology
Oncology
High evidence
+1

Carcinoid Syndrome and Neuroendocrine Tumours

Neuroendocrine tumours (NETs) represent a heterogeneous group of neoplasms arising from neuroendocrine cells distributed... MRCP exam preparation.

Neuroendocrine Tumours5 Jan 2026Peer reviewed
Oncology
Gastroenterology
High evidence
MRCP
+1

Cervical Cancer

The overwhelming majority (99.7%) of cervical cancers are caused by persistent infection with high-risk Human Papillomavirus (hrHPV) , particularly types 16 and 18. The disease typically develops over 10-15 years...

Gynae-Oncology6 Jan 2026Peer reviewed
Obstetrics & Gynaecology
Oncology
High evidence

Cervical Intraepithelial Neoplasia

CIN is typically asymptomatic and detected through organized cervical screening programmes using HPV testing and/or cervical cytology. The introduction of HPV-based primary screening has significantly improved...

Colposcopy9 Jan 2026Peer reviewed
Obstetrics & Gynaecology
Oncology
High evidence
+1

Chondrosarcoma (Adult)

Chondrosarcoma is a malignant bone tumour producing cartilaginous matrix and represents the second most common primary bone malignancy after osteosarcoma, accounting for approximately 20% of primary bone malignancies....

Bone Tumours6 Jan 2026Peer reviewed
Orthopaedics
Oncology
High evidence
+1

Colorectal Cancer

The disease demonstrates significant geographical variation in incidence, with highest rates observed in developed countries, reflecting the impact of dietary factors, sedentary lifestyle, and increased longevity....

GI Oncology6 Jan 2026Peer reviewed
Gastroenterology
Oncology
High evidence
+1

Cushing's Syndrome

The pathophysiology involves systemic dysregulation of protein and fat metabolism, creating a catabolic state characterized by proximal muscle wasting, skin thinning, and paradoxical central obesity. Diagnostic...

Pituitary Surgery6 Jan 2026Peer reviewed
Endocrinology
Neurosurgery
High evidence
+1

End of Life Care (Last Days of Life)

End of Life Care encompasses the multidimensional care provided during the last days to hours of life when a person is recognised as approaching death. This critical phase represents a transition from...

Terminal Care6 Jan 2026Peer reviewed
Palliative Care
Geriatrics
High evidence
+1

Endometrial Cancer

This aphorism encapsulates the fundamental pathophysiology of Type I endometrial cancer, where prolonged exposure to estrogen without adequate progesterone opposition drives malignant transformation.

Gynae-Oncology6 Jan 2026Peer reviewed
Obstetrics & Gynaecology
Oncology
High evidence

Ewing's Sarcoma

Histologically, Ewing's sarcoma belongs to the Ewing sarcoma family of tumours (ESFT) , characterized as a "small round blue cell tumour" with a pathognomonic molecular signature: the EWSR1-FLI1 fusion gene resulting...

Bone Tumours7 Jan 2026Peer reviewed
Orthopaedics
Paediatric Oncology
High evidence
+1

Gastric Cancer

The strongest modifiable risk factor is chronic infection with Helicobacter pylori , classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC). Other significant risk factors include...

Upper GI Surgery6 Jan 2026Peer reviewed
Gastroenterology
General Surgery
High evidence
+2

Hepatocellular Carcinoma (HCC)

The major risk factors are chronic viral hepatitis (hepatitis B virus [HBV] and hepatitis C virus [HCV]), alcohol-related liver disease, and increasingly non-alcoholic steatohepatitis (NASH), now termed metabolic...

Liver6 Jan 2026Peer reviewed
Gastroenterology
Oncology
High evidence
+1

Hodgkin Lymphoma

The disease exhibits a bimodal age distribution with peaks at 15-35 years (young adults) and 55 years (older adults). Patients typically present with painless lymphadenopathy , often cervical or supraclavicular, with...

Lymphoma11 Jan 2026Peer reviewed
Haematology
Oncology
High evidence
+1

Human Papillomavirus (HPV) Infection

Human Papillomavirus (HPV) is a double-stranded DNA virus of the Papillomaviridae family, representing the most common sexually transmitted infection (STI) worldwide . Over 200 HPV genotypes have been identified, with...

STIs7 Jan 2026Peer reviewed
Infectious Diseases
Obstetrics & Gynaecology
High evidence
+4

Hyperviscosity Syndrome

Key Facts Cause : IgM paraprotein (Waldenström's 85%), IgA/IgG3 (myeloma 10-15%), cellular (polycythaemia less than 5%) Classic triad : Neurological (70%) + visual (60%) + bleeding (50%) symptoms Diagnosis : Serum...

Plasma Cell Dyscrasias7 Jan 2026Peer reviewed
Haematology
Oncology
High evidence
+1

Lambert-Eaton Myasthenic Syndrome (LEMS)

Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder of the neuromuscular junction characterized by pr... MRCP exam preparation.

Neuromuscular Diseases7 Jan 2026Peer reviewed
Neurology
Oncology
High evidence
MRCP
+1

Lambert-Eaton Myasthenic Syndrome (LEMS)

The clinical hallmark is proximal muscle weakness , predominantly affecting the lower limbs, producing the characteristic complaint of "heavy legs" and difficulty rising from a chair or climbing stairs. The...

Neuromuscular6 Jan 2026Peer reviewed
Neurology
Oncology
High evidence

Leukaemia (Adult)

Leukaemia represents a heterogeneous group of clonal haematological malignancies characterised by the uncontrolled proliferation of abnormal white blood cells (WBCs) in the bone marrow and peripheral blood. These...

Myeloid/Lymphoid Malignancy6 Jan 2026Peer reviewed
Haematology
Oncology
High evidence
+1

Lung Cancer

Comprehensive, evidence-based guide to Lung Cancer covering epidemiology, molecular pathophysiology, TNM 8 staging with detailed substaging, EGFR/ALK/ROS1 molecular subtypes, immunotherapy (PD-L1 testing), LDCT...

Thoracic Oncology10 Jan 2026Peer reviewed
Respiratory Medicine
Oncology
High evidence
+1

Lymphadenopathy

The generalist's challenge is to filter the "benign majority" from the "malignant minority". While less than 1% of primary care patients with lymphadenopathy have malignancy, this rises to 40-60% in specialist...

Lymphoma2 Jan 2026Peer reviewed
General Practice
ENT
High evidence
+2

Lymphoma (Adult)

Lymphomas are a heterogeneous group of malignancies arising from lymphoid tissue, representing the fifth most common cancer in developed countries. They are broadly classified into Hodgkin lymphoma (HL) and...

Lymphoid Malignancy5 Jan 2025Peer reviewed
Haematology
Oncology
High evidence
+1

Malignant Melanoma

Global Burden : Over 324,000 new cases diagnosed annually worldwide, with melanoma representing the 17th most common cancer globally. Incidence Variation : Highest in Australia/New Zealand (50-60 per 100,000),...

Skin Cancer10 Jan 2026Peer reviewed
Dermatology
Oncology
High evidence
+1

Malignant Mesothelioma

This malignancy is intrinsically linked to asbestos exposure, with a characteristic latency period of 20-50 years between first exposure and clinical presentation. Due to peak asbestos utilization in the...

Thoracic Oncology6 Jan 2026Peer reviewed
Respiratory Medicine
Oncology
High evidence
+1

Melanoma

A comprehensive guide to Malignant Melanoma covering epidemiology, molecular pathophysiology (BRAF/NRAS/KIT mutations), AJCC 8th edition staging, sentinel lymph node biopsy, and modern immunotherapy/targeted therapy...

Skin Cancer5 Jan 2026Peer reviewed
Dermatology
Oncology
High evidence
+1

Meningioma

Comprehensive evidence-based guide to meningiomas - the most common primary intracranial tumour. Covers WHO grading, molecular classification, the pathognomonic 'dural tail' sign, Simpson grading for surgical...

Neuro-oncology5 Jan 2026Peer reviewed
Neurosurgery
Oncology
High evidence
FRCS (Neurosurgery)
+1

Metastatic Bone Disease

The "Big 5" primary carcinomas responsible for over 80% of bone metastases are Breast, Prostate, Lung, Kidney (Renal), and Thyroid - remembered by the mnemonic "Pb KTL" (Lead Kettle). Bone metastases are classified by...

Bone Tumours10 Jan 2026Peer reviewed
Orthopaedics
Oncology
High evidence
+1

Metastatic Spinal Cord Compression

Metastatic spinal cord compression (MSCC) is an oncological emergency occurring in 5-10% of cancer patients where spinal... MRCP, FRACP exam preparation.

Spinal Surgery11 Jan 2026Peer reviewed
Oncology
Emergency Medicine
High evidence
MRCP
+2

Metastatic Spinal Cord Compression (MSCC)

The cardinal presenting symptom is pain (present in 83-95% of cases), which characteristically precedes neurological deterioration by weeks to months. This pain is often nocturnal (worse at night due to venous...

Spine6 Jan 2026Peer reviewed
Spinal Surgery
Oncology
High evidence
+1

Molar Pregnancy (Hydatidiform Mole)

A molar pregnancy (hydatidiform mole) is a form of gestational trophoblastic disease (GTD) characterised by abnormal pro... MRCOG exam preparation.

Gestational Trophoblastic Disease6 Jan 2026Peer reviewed
Obstetrics & Gynaecology
Oncology
MRCOG
+1

Multiple Endocrine Neoplasia Type 2 (MEN 2)

A comprehensive, evidence-based guide to Multiple Endocrine Neoplasia Type 2 syndromes (MEN 2A and 2B), focusing on RET proto-oncogene mutations, genotype-phenotype correlations, prophylactic thyroidectomy timing,...

Thyroid Surgery10 Jan 2026Peer reviewed
Endocrinology
Genetics
High evidence
+2

Nausea and Vomiting in Palliative Care

Nausea and vomiting are among the most distressing and debilitating symptoms in palliative care, affecting 40-70% of patients with advanced cancer and up to 60% of patients in the terminal phase. Effective management...

Symptom Control6 Jan 2026Peer reviewed
Palliative Care
Oncology
High evidence
+1

Neuroblastoma

The clinical spectrum is remarkably heterogeneous, ranging from spontaneous regression in low-risk infants to aggressive metastatic disease in older children. This biological diversity reflects profound differences in...

Solid Tumours7 Jan 2026Peer reviewed
Paediatric Oncology
Paediatrics
High evidence
+1

Neurofibromatosis Type 1 (NF1)

NF1 is an autosomal dominant disorder caused by loss-of-function mutations in the NF1 tumour suppressor gene located on chromosome 17q11.2 . This gene encodes neurofibromin , a large cytoplasmic protein of 2,818 amino...

Neurocutaneous Syndromes9 Jan 2025Peer reviewed
Neurology
Genetics
High evidence
+2

Neutropenic Sepsis

Neutropenic Sepsis (Febrile Neutropenia, FN) is a life-threatening oncological emergency defined by fever in the presenc... MRCP exam preparation.

Infectious Diseases6 Jan 2026Peer reviewed
Oncology
High evidence
MRCP

Oesophageal Cancer (Adult)

Oesophageal cancer is a highly aggressive malignancy of the oesophagus with two distinct histological subtypes: adenocar... MRCP, FRCS exam preparation.

Oesophago-gastric Cancer7 Jan 2026Peer reviewed
Gastroenterology
Oncology
High evidence
MRCP
+1

Osteosarcoma

Osteosarcoma is the most common primary malignant bone tumour, accounting for approximately 20% of all primary bone canc... MRCP, MRCS, FRCS Orth, FRACS Orth ex

Bone Tumours11 Jan 2026Peer reviewed
Orthopaedic Oncology
Paediatric Oncology
High evidence
MRCP, MRCS, FRCS Orth, FRACS Orth
+1

Ovarian Cancer (Adult)

Ovarian cancer is the deadliest gynaecological malignancy and the fifth leading cause of cancer death in women in developed countries. Despite accounting for only 3% of all female cancers, it causes more deaths than...

Gynaecological Oncology6 Jan 2025Peer reviewed
Obstetrics & Gynaecology
Oncology
High evidence
+2

Palliative & Oncological Emergencies

Oncological emergencies represent acute, life-threatening or function-threatening complications that can occur at any stage of malignancy, from initial presentation through to end-of-life care. These emergencies...

Acute Oncology6 Jan 2026Peer reviewed
Palliative Care
Oncology
High evidence
+1

Palliative Pain Management

Effective pain management is the cornerstone of palliative care, affecting 70-90% of patients with advanced cancer and requiring systematic, evidence-based approaches. The principles are guided by the WHO Analgesic...

Pain Medicine6 Jan 2025Peer reviewed
Palliative Care
General Practice
High evidence
+1

Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC) represents approximately 95% of all pancreatic malignancies and is the 4th leading cause of cancer-related mortality in Western countries, with a devastating 5-year survival...

GI Oncology6 Jan 2026Peer reviewed
Oncology
HPB Surgery
High evidence
+1

Penile Cancer

Human papillomavirus (HPV), particularly high-risk types 16 and 18, is detected in 30-50% of penile cancers through molecular studies, establishing a viral oncogenic pathway analogous to cervical cancer. Chronic...

Uro-oncology6 Jan 2026Peer reviewed
Urology
Oncology
High evidence
+1

Plantar Fibromatosis

The hallmark of management is conservative first : surgery is fraught with extremely high recurrence rates (57-100% for simple excision), making non-operative modalities including custom orthotics, intralesional...

Foot and Ankle6 Jan 2025Peer reviewed
Orthopaedics
Oncology
High evidence
+1

Prostate Cancer

Prostate cancer represents the most common non-cutaneous malignancy in men worldwide, with an estimated 1.4 million new ... MRCP, FRCS(Urol) exam preparation.

Genitourinary Oncology10 Jan 2026Peer reviewed
Urology
Oncology
High evidence
MRCP

Prostate-Specific Antigen (PSA) Testing in Adults

Prostate-Specific Antigen (PSA) is a serine protease glycoprotein produced almost exclusively by prostatic epithelial cells. It functions physiologically to liquefy the seminal coagulum, but its clinical utility lies...

Prostate Cancer Screening9 Jan 2026Peer reviewed
Urology
Oncology
High evidence
+1

Renal Cell Carcinoma (RCC)

A comprehensive guide to RCC, covering molecular pathophysiology, histological subtypes, Von Hippel-Lindau association, paraneoplastic syndromes, nephron-sparing surgery, and contemporary targeted biological therapies...

Urological Oncology6 Jan 2026Peer reviewed
Urology
Oncology
High evidence

Retinoblastoma

The disease typically presents before the age of 5 years, with a median diagnosis at 18 months in bilateral cases and 24 months in unilateral disease. The critical clinical challenge lies in achieving the optimal...

Ocular Oncology6 Jan 2026Peer reviewed
Ophthalmology
Paediatrics
High evidence
+1

Squamous Cell Carcinoma (Skin)

Cutaneous Squamous Cell Carcinoma (cSCC) is a malignant neoplasm arising from epidermal keratinocytes, representing the second most common skin cancer after basal cell carcinoma. Unlike basal cell carcinoma, cSCC...

Skin Cancer6 Jan 2026Peer reviewed
Dermatology
Plastic Surgery
High evidence
+1

Superior Vena Cava Obstruction

Superior vena cava obstruction (SVCO) represents compression, invasion, or thrombosis of the superior vena cava (SVC), i... MRCP exam preparation.

Thoracic Oncology7 Jan 2025Peer reviewed
Oncology
Emergency Medicine
High evidence
MRCP
+1

Superior Vena Cava Syndrome

Superior vena cava syndrome (SVCS) is a clinical syndrome resulting from obstruction of blood flow through the superior ... MRCP exam preparation.

Thoracic Oncology10 Jan 2026Peer reviewed
Oncology
MRCP

Testicular Cancer

The fundamental clinical distinction is between Seminomas (slow growing, radiosensitive, elderly men) and Non-Seminomatous GCTs (NSGCTs - aggressive, early metastasis, young men).

Genitourinary Oncology5 Jan 2026Peer reviewed
Urology
Oncology
High evidence
+1

Thyroid Cancer

The vast majority ( 90%) of thyroid cancers are differentiated thyroid cancers (DTC) , comprising papillary and follicular subtypes, which originate from thyroid follicular epithelial cells and retain the ability to...

Head and Neck6 Jan 2026Peer reviewed
Endocrinology
General Surgery
High evidence
+1

Tumour Lysis Syndrome

Key Facts Timing : Usually 12-72 hours after chemotherapy initiation; can be spontaneous High-risk tumours : Burkitt lymphoma, ALL, high-grade NHL, AML with hyperleukocytosis Metabolic tetrad : ↑K+, ↑uric acid,...

10 Jan 2026Peer reviewed
Oncology
Haematology
High evidence
+2

Vestibular Schwannoma

The classic clinical triad comprises: Unilateral progressive sensorineural hearing loss (95% of cases) Tinnitus (unilateral, typically high-pitched) Vestibular dysfunction (imbalance more common than true vertigo)

Skull Base Surgery6 Jan 2026Peer reviewed
Neurosurgery
ENT
High evidence
+1

Vulval Cancer

HPV-dependent pathway (30-40%): Affects younger women (40-60 years), associated with High-Risk HPV infection (types 16, 18), characterized by usual-type Vulval Intraepithelial Neoplasia (uVIN), and demonstrates...

Gynaecological Oncology6 Jan 2026Peer reviewed
Obstetrics & Gynaecology
Oncology
High evidence
+1